|Treatment options||Interferon-based treatment (detail)||Direct acting antiviral treatment (detail)|
Your treatment depends on what hep C genotype you have got:
If you have hep C genotype 1a or 1b, you might be offered (in no particular order) Harvoni (on its own), or Sovaldi plus Daklinza (taken together), or Zepatier (own its own or with ribavirin).
If you have hep C genotype 1a, you might be offered VIEKIRA PAK plus ribavirin (taken together)
If you have hep C genotype 1b, you might be offered VIEKIRA PAK.
If you have hep C genotype 2, you are offered Sovaldi plus Ibavyr (taken together).
If you have hep C genotype 3, you are offered Sovaldi plus Daklinza (taken together, with or without ribavirin).
If you have hep C genotype 4, you are offered Zepatier (on its own or with ribavirin).
If you have hep C genotypes 5 or 6, you remain limited to Sovaldi taken with pegylated interferon injections plus ribavirin pills.
Other drug combinations are approved and available but those mentioned above are the ones with best response and tolerability.
For more news, subscribe to The Champion e-newsletter, and call the Hepatitis Infoline (1800 803 990).
This page was last updated 25 May 2017.
Content drawn from Australian Recommendations for the Management of Hepatitis C Virus Infection: a Consensus Statement 2017, and publications of ASHM, The Kirby Institute and The Centre for Social Research in Health, and vetted by our Medical and Research Advisory Panel.